Atlantic Monthly looks at the advertising battle waged by the makers of Anacin, which seeks to set its product apart by claiming to be bigger or better than ordinary aspirin; examines the threat to market shares posed by ibuprofen and acetaminophen, October 1988.
This file is not available for digital download. IRE members may place an order by emailing rescntr@ire.org
